Vladimir Khavinson's Research Program

Khavinson Bioregulators: The Complete Guide

Last updated: October 3, 2026

Ultra-short peptides proposed to act on gene expression rather than surface receptors (a hypothesis from Khavinson's group). Here's a breakdown of 11 of them and some example combinations.

Khavinson
Russian Research
Programme
11
Bioregulators
Cataloged Here

Build your own printable peptide tracker

A personalized injection log, weekly dosing schedule and dated calendar: your compounds filled in, ready to print. Free to build and preview; $5/month to unlock printing.

Stacking compounds? Check interactions first →

Build your tracker →
Older man and woman sit on a porch watering potted ferns together in sunlight
Photo: Marquette654 · CC0 1.0 · source

Not Like Other Peptides

As general textbook background, many peptide hormones act through cell-surface receptors. Khavinson's group proposes that bioregulators work differently. It is a hypothesis, not an established mechanism.

🔗
Traditional Peptides
  • General textbook contrast, not a claim about any specific compound
  • Bind cell surface receptors (GPCR, tyrosine kinase, etc.)
  • Trigger signaling cascade inside cell
  • Signal degrades; effect fades when peptide clears
  • Gene-expression changes, where they occur, are downstream of receptor signaling
🧬
Khavinson Bioregulators
  • Ultra-short (2–4 amino acids), proposed to pass through the cell membrane
  • Proposed to enter the cell nucleus
  • Hypothesized to interact with DNA promoter regions and histones
  • Proposed to regulate gene expression (a hypothesis, not established)
  • Examples: Epitalon (AEDG), Pinealon (EDR), Vilon (KE)

11 Khavinson Bioregulators

Khavinson's group describes each bioregulator as acting on a particular organ or tissue. That organ specificity is proposed, not established, and some entries (Epitalon: pineal gland and retina) are linked to more than one tissue. Khavinson's group has described more bioregulators than the 11 covered here; this is a selection, not a complete list.

Epitalon
Proposed target: Pineal Gland / Retina
AEDG
Proposed effects (not established): telomerase (hTERT) activation, melatonin circadian rhythm effects, retinal integrity, and a hypothesized histone (H1/3, H1/6) interaction. Dose-dependent telomere length extension in normal human cell lines in vitro (PMC12411320).
Pinealon
Proposed target: Brain Cortex
EDR
Proposed effects (not established): neuroprotection under hypoxic stress, NMDA excitotoxicity suppression, serotonin modulation.
Vesugen
Proposed target: Blood Vessels
KED
Proposed vascular bioregulator targeting blood vessel wall (endothelial) cells. Vascular and microcirculation effects are not established.
Vilon
Proposed target: Thymus (Immune)
KE
Proposed immune bioregulator aimed at T-cell function. Dipeptide (just 2 amino acids). Proposed uses (not established): age-related immune decline (immunosenescence), autoimmune regulation, and thymic regeneration.
Thymalin
Proposed target: Thymus (Immune)
Polypeptide
A thymic polypeptide complex extracted from calf thymus, not a single short sequence, so the 2–4 amino acid description above does not apply to it. Included here because it is part of Khavinson's bioregulator program.
Cortagen
Proposed target: Brain Cortex
AEDP
Proposed brain cortex bioregulator. Four amino acids vs Pinealon's three. Proposed uses (not established): neurological conditions, cognitive decline, and brain aging. Shares the AED motif with Epitalon.
Crystagen
Proposed target: Immune System
EDP
Proposed immune bioregulator, described as acting on immune cells more broadly than the thymus. Proposed uses (not established): immune enhancement in aging, post-infection recovery, and immune dysfunction. Tripeptide with glutamic acid-aspartic acid-proline sequence.
Ovagen
Proposed target: Liver / GI Tract
Proposed liver and gastrointestinal bioregulator. Proposed uses (not established): liver cell regeneration, gut integrity, and protection against hepatic damage.
Cartalax
Proposed target: Cartilage / MSK
AED
Proposed cartilage (chondrocyte) bioregulator. Proposed uses (not established): joint health, cartilage regeneration, and protection against age-related musculoskeletal decline. Shares the AED core with Epitalon (AEDG).
Chonluten
Proposed target: Lungs / Bronchial
EDG
Proposed bronchial and lung tissue bioregulator. Proposed uses (not established): respiratory epithelium protection, pulmonary aging, and inflammation in lung tissue. EDG sequence shares the ED core with Pinealon.
Testagen
Proposed target: Testes / Reproductive
KEDG
Proposed testicular bioregulator (Leydig and Sertoli cells). Proposed uses (not established): testosterone production support, spermatogenesis, and male reproductive aging. Four amino acids: lysine-glutamic acid-aspartic acid-glycine.

Example Combinations

Example combinations, listed for reference only: this page does not give recommendations or protocols. Each rationale below rests on proposed, unestablished effects, and no controlled human trial cited here has tested any of these combinations.

🌙 Sleep + Cognition
Epitalon (AEDG) Pinealon (EDR)
Rationale offered: Epitalon's proposed pineal and melatonin/circadian effects plus Pinealon's proposed neuroprotective effects. Neither set of effects is established, and the combination has not been tested.
⏳ Pineal + Immune + Vascular
Epitalon (AEDG) Vilon (KE) Vesugen (KED)
Rationale offered: combines the proposed targets of Epitalon (pineal/telomerase), Vilon (immune) and Vesugen (vascular). None of these effects is established, and the combination has not been tested.
🧠 Brain-Focused Combination
Pinealon (EDR) Vesugen (KED) Cortagen (AEDP)
Rationale offered: pairs the proposed brain bioregulators Pinealon and Cortagen with Vesugen, a proposed vascular bioregulator. None of these effects is established, and the combination has not been tested.
🔄 Four-Compound Combination
Epitalon (AEDG) Pinealon (EDR) Vilon (KE) Vesugen (KED)
Rationale offered: combines the proposed pineal, brain, immune and vascular targets of the four compounds. Untested as a combination.

Timing & Cycling

Bioregulators are usually discussed as short courses with breaks rather than continuous daily use. This page has not sourced specific course lengths, rest periods, or cycles per year, so none are listed on this page.

Oral Bioavailability of Ultra-Short Peptides

Most peptides are broken down by stomach acid and gut enzymes. The case for oral bioregulators rests on their very short length (a proposed mechanism, not a demonstrated one).

🔬 The Proposed Rationale

Most peptides taken by mouth are broken down by gut proteases before absorption, so the biological signal is largely lost in transit.

Khavinson bioregulators are ultra-short (2–4 amino acids) — and the proposal is that the di- and tripeptides could be absorbed via the intestinal di/tripeptide transporter PEPT1. Whether the tetrapeptides (Epitalon AEDG, Cortagen AEDP, Testagen KEDG) cross the gut wall intact is not established.

Oral survival and efficacy have not been demonstrated in controlled human studies. Treat the oral route as unproven.

1
Gastric Passage
Proposed: very short length may help them survive the stomach (not directly demonstrated)
2
PEPT1 Transport
Proposed: the intestinal di/tripeptide transporter PEPT1 may carry the di- and tripeptides across the gut wall; tetrapeptide transport is unestablished
3
Nuclear Entry
Proposed: once in circulation, the ultra-short size may allow entry into cells and the nucleus (a hypothesis from Khavinson's group)

Who Researches Bioregulators?

This Research Is Commonly Explored By People Who...

  • Are interested in Khavinson peptide bioregulators and their proposed gene expression regulation mechanisms
  • Want to understand the proposed organ-specificity hypothesis for short peptides (2-4 amino acids) from Khavinson's group, a hypothesis this page notes is not established
  • Are exploring longevity and anti-aging research beyond mainstream Western approaches
  • Want an overview of Epitalon, Vilon, Cortagen, and the other bioregulators cataloged on this page, along with the tissue each is proposed to target
  • Are curious about the intersection of peptide therapy and epigenetic regulation

This Research May Not Be Relevant If...

  • You expect Western-standard randomized controlled trials: this page does not cite any for these compounds
  • You're looking for acute symptom treatment: bioregulators are usually discussed as course-based, not acute, interventions
  • You want widely available, pharmacy-dispensed medications: most bioregulators are specialty peptide products
📚

Want the Complete Protocol Guide?

Dosing schedules, interaction warnings, and cycle protocols for 20+ compounds, all in one place.


Get the Guide: $19 (normally $29) →
The Peptide Buyer’s Playbook ($19)
Affiliate Partner

Research-Grade Peptides

Research peptides are not FDA-approved for human use. Review each product's certificate of analysis before buying.

Browse Swiss Chems →
Code HIGHPEP10: 10% off regular-priced items

Affiliate links support HighPeptides at no extra cost.

Important Disclaimer

This page is for educational and informational purposes only. It is not medical advice, and nothing here should be interpreted as a recommendation to use any bioregulator peptide. None of the Khavinson bioregulators cataloged on this page are approved by the FDA or EMA for human use. They are research compounds. Always consult a qualified healthcare provider before making any health decisions. HighPeptides does not sell peptides. This page contains affiliate links to vendors and supplies; see the affiliate disclosure.

📘

Get the Free 2026 Peptide Protocol Stack

Twelve compounds across four pillars: metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.